Skip to main content
Erschienen in: Clinical Oral Investigations 4/2019

17.09.2018 | Original Article

Immunostimulatory activity of low-molecular-weight hyaluronan on dendritic cells stimulated with Aggregatibacter actinomycetemcomitans or Porphyromonas gingivalis

verfasst von: Gustavo Monasterio, José Guevara, Juan Pablo Ibarra, Francisca Castillo, Jaime Díaz-Zúñiga, Carla Alvarez, Emilio A. Cafferata, Rolando Vernal

Erschienen in: Clinical Oral Investigations | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Periodontitis is a chronic inflammatory disease characterized by tooth-supporting tissue destruction, which is elicited by the host’s immune response triggered against periodonto-pathogen bacteria. During periodontal tissue destruction, extracellular matrix components are metabolized and fragmented. Some extracellular matrix component-derived fragments, such as low-molecular-weight hyaluronan (LMW-HA), have potent immunogenic potential, playing a role as damage-associated molecular patterns (DAMPs) during activation of immune cells. Dendritic cells (DCs) play a central role in the host’s immune response displayed during periodontitis; thus, this study aimed to analyze whether LMW-HA has an immunostimulatory activity on DCs when stimulated with periodonto-pathogen bacteria.

Materials and methods

LMW-HA-treated and non-treated DCs were stimulated with Aggregatibacter actinomycetemcomitans or Porphyromonas gingivalis and the mRNA expression for cytokines tumor necrosis factor-α (TNF-alpha), interleukin-1β (IL-1B), interleukin-6 (IL-6), and interleukin-23 (IL-23A) was quantified by RT-qPCR. In addition, transcription factors interferon regulatory factor 4 (IRF4), interferon regulatory factor 8 (IRF8), neurogenic locus notch homolog protein 2 (NOTCH2), and basic leucine zipper ATF-like transcription factor 3 (BATF3), involved in DC activation, were analyzed.

Results

Higher expression levels of TNF-alpha, IL-1B, IL-6, and IL-23A were detected in LMW-HA-treated DCs after bacterial infection, as compared with non-treated DCs. When LMW-HA-treated DCs were infected with A. actinomycetemcomitans, higher levels of IRF4, NOTCH2, and BATF3 were detected compared with non-treated cells; whereas against P. gingivalis infection, increased levels of IRF4 and NOTCH2 were detected.

Conclusion

LMW-HA plays an immunostimulatory role on the immune response triggered by DCs during infection with A. actinomycetemcomitans or P. gingivalis.

Clinical relevance

Detection of extracellular matrix component-derived fragments produced during periodontal tissue destruction, such as LMW-HA, could explain at least partly unsuccessful periodontal treatment and the chronicity of the disease.
Literatur
1.
Zurück zum Zitat Bansal J, Kedige SD, Anand S (2010) Hyaluronic acid: a promising mediator for periodontal regeneration. Indian J Dent Res 21(4):575CrossRefPubMed Bansal J, Kedige SD, Anand S (2010) Hyaluronic acid: a promising mediator for periodontal regeneration. Indian J Dent Res 21(4):575CrossRefPubMed
2.
Zurück zum Zitat Jiang D, Liang J, Noble PW (2011) Hyaluronan as an immune regulator in human diseases. Physiol Rev 91(1):221–264CrossRefPubMed Jiang D, Liang J, Noble PW (2011) Hyaluronan as an immune regulator in human diseases. Physiol Rev 91(1):221–264CrossRefPubMed
3.
Zurück zum Zitat Necas J, Bartosikova L, Brauner P, Kolar J (2008) Hyaluronic acid (hyaluronan): a review. Vet Med 53(8):397–411CrossRef Necas J, Bartosikova L, Brauner P, Kolar J (2008) Hyaluronic acid (hyaluronan): a review. Vet Med 53(8):397–411CrossRef
4.
Zurück zum Zitat Bowden DJ, Byrne CA, Alkhayat A, Eustace SJ, Kavanagh EC (2017) Injectable viscoelastic supplements: a review for radiologists. AJR Am J Roentgenol 209(4):883–888CrossRefPubMed Bowden DJ, Byrne CA, Alkhayat A, Eustace SJ, Kavanagh EC (2017) Injectable viscoelastic supplements: a review for radiologists. AJR Am J Roentgenol 209(4):883–888CrossRefPubMed
5.
Zurück zum Zitat Powell JD, Horton MR (2005) Threat matrix. Low-molecular-weight hyaluronan (HA) as a danger signal. Immunol Res 31(3):207–218CrossRefPubMed Powell JD, Horton MR (2005) Threat matrix. Low-molecular-weight hyaluronan (HA) as a danger signal. Immunol Res 31(3):207–218CrossRefPubMed
7.
Zurück zum Zitat Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR (2006) Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 177(2):1272–1281CrossRefPubMed Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR (2006) Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 177(2):1272–1281CrossRefPubMed
8.
Zurück zum Zitat Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC (2002) Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195(1):99–111CrossRefPubMedPubMedCentral Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC (2002) Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195(1):99–111CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Song L, Dong G, Guo L, Graves DT (2018) The function of dendritic cells in modulating the host response. Mol Oral Microbiol 33(1):13–21CrossRefPubMed Song L, Dong G, Guo L, Graves DT (2018) The function of dendritic cells in modulating the host response. Mol Oral Microbiol 33(1):13–21CrossRefPubMed
10.
Zurück zum Zitat Mildner A, Jung S (2014) Development and function of dendritic cell subsets. Immunity 40(5):642–656CrossRefPubMed Mildner A, Jung S (2014) Development and function of dendritic cell subsets. Immunity 40(5):642–656CrossRefPubMed
12.
Zurück zum Zitat Chandra J, Kuo PT, Hahn AM, Belz GT, Frazer IH (2017) Batf3 selectively determines acquisition of CD8+ dendritic cell phenotype and function. Immunol Cell Biol 95(2):215–223CrossRefPubMed Chandra J, Kuo PT, Hahn AM, Belz GT, Frazer IH (2017) Batf3 selectively determines acquisition of CD8+ dendritic cell phenotype and function. Immunol Cell Biol 95(2):215–223CrossRefPubMed
13.
Zurück zum Zitat Nizzoli G, Krietsch J, Weick A, Steinfelder S, Facciotti F, Gruarin P, Bianco A, Steckel B, Moro M, Crosti M, Romagnani C, Stölzel K, Torretta S, Pignataro L, Scheibenbogen C, Neddermann P, De Francesco R, Abrignani S, Geginat J (2013) Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses. Blood 122(6):932–942CrossRefPubMed Nizzoli G, Krietsch J, Weick A, Steinfelder S, Facciotti F, Gruarin P, Bianco A, Steckel B, Moro M, Crosti M, Romagnani C, Stölzel K, Torretta S, Pignataro L, Scheibenbogen C, Neddermann P, De Francesco R, Abrignani S, Geginat J (2013) Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses. Blood 122(6):932–942CrossRefPubMed
15.
Zurück zum Zitat Bedoui S, Heath WR (2015) Krüppel-ling of IRF4-dependent DCs into two functionally distinct DC subsets. Immunity 42(5):785–787CrossRefPubMed Bedoui S, Heath WR (2015) Krüppel-ling of IRF4-dependent DCs into two functionally distinct DC subsets. Immunity 42(5):785–787CrossRefPubMed
16.
Zurück zum Zitat Persson EK, Uronen-Hansson H, Semmrich M, Rivollier A, Hägerbrand K, Marsal J, Gudjonsson S, Håkansson U, Reizis B, Kotarsky K, Agace WW (2013) IRF4 transcription-factor-dependent CD103+CD11b+ dendritic cells drive mucosal T helper 17 cell differentiation. Immunity 38(5):958–969CrossRefPubMed Persson EK, Uronen-Hansson H, Semmrich M, Rivollier A, Hägerbrand K, Marsal J, Gudjonsson S, Håkansson U, Reizis B, Kotarsky K, Agace WW (2013) IRF4 transcription-factor-dependent CD103+CD11b+ dendritic cells drive mucosal T helper 17 cell differentiation. Immunity 38(5):958–969CrossRefPubMed
17.
Zurück zum Zitat Schlitzer A, McGovern N, Teo P, Zelante T, Atarashi K, Low D, Ho AW, See P, Shin A, Wasan PS, Hoeffel G, Malleret B, Heiseke A, Chew S, Jardine L, Purvis HA, Hilkens CM, Tam J, Poidinger M, Stanley ER, Krug AB, Renia L, Sivasankar B, Ng LG, Collin M, Ricciardi-Castagnoli P, Honda K, Haniffa M, Ginhoux F (2013) IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38(5):970–983CrossRefPubMedPubMedCentral Schlitzer A, McGovern N, Teo P, Zelante T, Atarashi K, Low D, Ho AW, See P, Shin A, Wasan PS, Hoeffel G, Malleret B, Heiseke A, Chew S, Jardine L, Purvis HA, Hilkens CM, Tam J, Poidinger M, Stanley ER, Krug AB, Renia L, Sivasankar B, Ng LG, Collin M, Ricciardi-Castagnoli P, Honda K, Haniffa M, Ginhoux F (2013) IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38(5):970–983CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Casale M, Moffa A, Vella P, Sabatino L, Capuano F, Salvinelli B, Lopez MA, Carinci F, Salvinelli F (2016) Hyaluronic acid: perspectives in dentistry. A systematic review. Int J Immunopathol Pharmacol 29(4):572–582CrossRefPubMedPubMedCentral Casale M, Moffa A, Vella P, Sabatino L, Capuano F, Salvinelli B, Lopez MA, Carinci F, Salvinelli F (2016) Hyaluronic acid: perspectives in dentistry. A systematic review. Int J Immunopathol Pharmacol 29(4):572–582CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Yamalik N, Kilinç K, Çağlayan F, Eratalay K, Çağlayan G (1998) Molecular size distribution analysis of human gingival proteoglycans and glycosaminoglycans in specific periodontal diseases. J Clin Periodontol 25(2):145–152CrossRefPubMed Yamalik N, Kilinç K, Çağlayan F, Eratalay K, Çağlayan G (1998) Molecular size distribution analysis of human gingival proteoglycans and glycosaminoglycans in specific periodontal diseases. J Clin Periodontol 25(2):145–152CrossRefPubMed
20.
Zurück zum Zitat Vernal R, Leon R, Herrera D, Garcia-Sanz JA, Silva A, Sanz M (2008) Variability in the response of human dendritic cells stimulated with Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans. J Periodontal Res 43(6):689–697CrossRefPubMed Vernal R, Leon R, Herrera D, Garcia-Sanz JA, Silva A, Sanz M (2008) Variability in the response of human dendritic cells stimulated with Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans. J Periodontal Res 43(6):689–697CrossRefPubMed
21.
Zurück zum Zitat Ke C, Wang D, Sun Y, Qiao D, Ye H, Zeng X (2013) Immunostimulatory and antiangiogenic activities of low molecular weight hyaluronic acid. Food Chem Toxicol 58:401–407CrossRefPubMed Ke C, Wang D, Sun Y, Qiao D, Ye H, Zeng X (2013) Immunostimulatory and antiangiogenic activities of low molecular weight hyaluronic acid. Food Chem Toxicol 58:401–407CrossRefPubMed
22.
Zurück zum Zitat Rizzo M, Bayo J, Piccioni F, Malvicini M, Fiore E, Peixoto E, García MG, Aquino JB, Gonzalez Campaña A, Podestá G, Terres M, Andriani O, Alaniz L, Mazzolini G (2014) Low molecular weight hyaluronan-pulsed human dendritic cells showed increased migration capacity and induced resistance to tumor chemoattraction. PLoS One 9(9):e107944CrossRefPubMedPubMedCentral Rizzo M, Bayo J, Piccioni F, Malvicini M, Fiore E, Peixoto E, García MG, Aquino JB, Gonzalez Campaña A, Podestá G, Terres M, Andriani O, Alaniz L, Mazzolini G (2014) Low molecular weight hyaluronan-pulsed human dendritic cells showed increased migration capacity and induced resistance to tumor chemoattraction. PLoS One 9(9):e107944CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Braza F, Brouard S, Chadban S, Goldstein DR (2016) Role of TLRs and DAMPs in allograft inflammation and transplant outcomes. Nat Rev Nephrol 12(5):281–290CrossRefPubMedPubMedCentral Braza F, Brouard S, Chadban S, Goldstein DR (2016) Role of TLRs and DAMPs in allograft inflammation and transplant outcomes. Nat Rev Nephrol 12(5):281–290CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Hull RL, Bogdani M, Nagy N, Johnson PY, Wight TN (2015) Hyaluronan: a mediator of islet dysfunction and destruction in diabetes? J Histochem Cytochem 63(8):592–603CrossRefPubMedPubMedCentral Hull RL, Bogdani M, Nagy N, Johnson PY, Wight TN (2015) Hyaluronan: a mediator of islet dysfunction and destruction in diabetes? J Histochem Cytochem 63(8):592–603CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Fujioka-Kobayashi M, Müller HD, Mueller A, Lussi A, Sculean A, Schmidlin PR, Miron RJ (2017) In vitro effects of hyaluronic acid on human periodontal ligament cells. BMC Oral Health 17(1):44CrossRefPubMedPubMedCentral Fujioka-Kobayashi M, Müller HD, Mueller A, Lussi A, Sculean A, Schmidlin PR, Miron RJ (2017) In vitro effects of hyaluronic acid on human periodontal ligament cells. BMC Oral Health 17(1):44CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Tanne Y, Tanimoto K, Okuma S, Kunimatsu R, Hirose N, Mitsuyoshi T, Tanne K (2013) Effects of hyaluronan oligosaccharides on apoptosis of human gingival fibroblasts. Open J Stomatol 3(01):19CrossRef Tanne Y, Tanimoto K, Okuma S, Kunimatsu R, Hirose N, Mitsuyoshi T, Tanne K (2013) Effects of hyaluronan oligosaccharides on apoptosis of human gingival fibroblasts. Open J Stomatol 3(01):19CrossRef
27.
Zurück zum Zitat Wang Y, Han G, Guo B, Huang J (2016) Hyaluronan oligosaccharides promote diabetic wound healing by increasing angiogenesis. Pharmacol Rep 68(6):1126–1132CrossRefPubMed Wang Y, Han G, Guo B, Huang J (2016) Hyaluronan oligosaccharides promote diabetic wound healing by increasing angiogenesis. Pharmacol Rep 68(6):1126–1132CrossRefPubMed
28.
Zurück zum Zitat Yamawaki H, Hirohata S, Miyoshi T, Takahashi K, Ogawa H, Shinohata R, Demircan K, Kusachi S, Yamamoto K, Ninomiya Y (2009) Hyaluronan receptors involved in cytokine induction in monocytes. Glycobiology 19(1):83–92CrossRefPubMed Yamawaki H, Hirohata S, Miyoshi T, Takahashi K, Ogawa H, Shinohata R, Demircan K, Kusachi S, Yamamoto K, Ninomiya Y (2009) Hyaluronan receptors involved in cytokine induction in monocytes. Glycobiology 19(1):83–92CrossRefPubMed
29.
Zurück zum Zitat Murphy KM (2013) Transcriptional control of dendritic cell development. Adv Immunol 120:239–267CrossRefPubMed Murphy KM (2013) Transcriptional control of dendritic cell development. Adv Immunol 120:239–267CrossRefPubMed
30.
32.
Zurück zum Zitat Geginat J, Nizzoli G, Paroni M, Maglie S, Larghi P, Pascolo S, Abrignani S (2015) Immunity to pathogens taught by specialized human dendritic cell subsets. Front Immunol 6:527CrossRefPubMedPubMedCentral Geginat J, Nizzoli G, Paroni M, Maglie S, Larghi P, Pascolo S, Abrignani S (2015) Immunity to pathogens taught by specialized human dendritic cell subsets. Front Immunol 6:527CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Briseño CG, Haldar M, Kretzer NM, Wu X, Theisen DJ, Kc W, Durai V, Grajales-Reyes GE, Iwata A, Bagadia P, Murphy TL, Murphy KM (2016) Distinct transcriptional programs control cross-priming in classical and monocyte-derived dendritic cells. Cell Rep 15(11):2462–2474CrossRefPubMedPubMedCentral Briseño CG, Haldar M, Kretzer NM, Wu X, Theisen DJ, Kc W, Durai V, Grajales-Reyes GE, Iwata A, Bagadia P, Murphy TL, Murphy KM (2016) Distinct transcriptional programs control cross-priming in classical and monocyte-derived dendritic cells. Cell Rep 15(11):2462–2474CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Balan S, Ollion V, Colletti N, Chelbi R, Montanana-Sanchis F, Liu H, Vu Manh TP, Sanchez C, Savoret J, Perrot I, Doffin AC, Fossum E, Bechlian D, Chabannon C, Bogen B, Asselin-Paturel C, Shaw M, Soos T, Caux C, Valladeau-Guilemond J, Dalod M (2014) Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells. J Immunol 193(4):1622–1635CrossRefPubMedPubMedCentral Balan S, Ollion V, Colletti N, Chelbi R, Montanana-Sanchis F, Liu H, Vu Manh TP, Sanchez C, Savoret J, Perrot I, Doffin AC, Fossum E, Bechlian D, Chabannon C, Bogen B, Asselin-Paturel C, Shaw M, Soos T, Caux C, Valladeau-Guilemond J, Dalod M (2014) Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells. J Immunol 193(4):1622–1635CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Termeer CC, Hennies J, Voith U, Ahrens T, Weiss JM, Prehm P, Simon JC (2000) Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 165(4):1863–1870CrossRefPubMed Termeer CC, Hennies J, Voith U, Ahrens T, Weiss JM, Prehm P, Simon JC (2000) Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 165(4):1863–1870CrossRefPubMed
36.
Zurück zum Zitat Martín-Fontecha A, Sebastiani S, Höpken UE, Uguccioni M, Lipp M, Lanzavecchia A, Sallusto F (2003) Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 198(4):615–621CrossRefPubMedPubMedCentral Martín-Fontecha A, Sebastiani S, Höpken UE, Uguccioni M, Lipp M, Lanzavecchia A, Sallusto F (2003) Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 198(4):615–621CrossRefPubMedPubMedCentral
Metadaten
Titel
Immunostimulatory activity of low-molecular-weight hyaluronan on dendritic cells stimulated with Aggregatibacter actinomycetemcomitans or Porphyromonas gingivalis
verfasst von
Gustavo Monasterio
José Guevara
Juan Pablo Ibarra
Francisca Castillo
Jaime Díaz-Zúñiga
Carla Alvarez
Emilio A. Cafferata
Rolando Vernal
Publikationsdatum
17.09.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 4/2019
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-018-2641-5

Weitere Artikel der Ausgabe 4/2019

Clinical Oral Investigations 4/2019 Zur Ausgabe

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.